Abstract |
Mammalian target of rapamycin (mTOR), a serine/threonine protein kinase, forms two different complexes, complex 1 and 2, and plays a key role in the regulation of Akt signaling-mediated cell proliferation and transformation. This study reveals aschantin, a natural compound abundantly found in Magnolia flos, as a novel mTOR kinase inhibitor. Aschantin directly targeted the active pocket of mTOR kinase domain by competing with adenosine triphosphate ( ATP), but not PI3K and PDK1. Aschantin inhibited epidermal growth factor ( EGF)-induced full activation of Akt by phosphorylation at Ser473/Thr308, resulting in inhibition of the mTORC2/Akt and Akt/ mTORC1/ p70S6K signaling pathways and activation of GSK3β by abrogation of Akt-mediated GSK3β phosphorylation at Ser9. The activated GSK3β inhibited cell proliferation by c-Jun phosphorylation at Ser243, which facilitated destabilization and degradation of c-Jun through the ubiquitination-mediated proteasomal degradation pathway. Notably, aschantin treatment decreased c-Jun stability through inhibition of the mTORC2-Akt signaling pathway, which suppressed EGF-induced anchorage-independent cell transformation in non-malignant JB6 Cl41 and HaCaT cells and colony growth of LNCaP and MIAPaCa-2 cancer cells in soft agar. Altogether, the results show that aschantin targets mTOR kinase and destabilizes c-Jun, which implicate aschantin as a potential chemopreventive or therapeutic agent.
|
Authors | Cheol-Jung Lee, Jeong-Hoon Jang, Ji-Young Lee, Mee-Hyun Lee, Yan Li, Hyung Won Ryu, Kyung-Il Choi, Zigang Dong, Hye Suk Lee, Sei-Ryang Oh, Young-Joon Surh, Yong-Yeon Cho |
Journal | Carcinogenesis
(Carcinogenesis)
Vol. 36
Issue 10
Pg. 1223-34
(Oct 2015)
ISSN: 1460-2180 [Electronic] England |
PMID | 26243309
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]. |
Chemical References |
- Benzodioxoles
- Lignans
- Multiprotein Complexes
- aschantin
- Epidermal Growth Factor
- MTOR protein, human
- GSK3B protein, human
- Glycogen Synthase Kinase 3 beta
- Gsk3b protein, mouse
- Mechanistic Target of Rapamycin Complex 1
- Mechanistic Target of Rapamycin Complex 2
- Proto-Oncogene Proteins c-akt
- TOR Serine-Threonine Kinases
- Glycogen Synthase Kinase 3
|
Topics |
- Animals
- Benzodioxoles
(administration & dosage)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Transformation, Neoplastic
(drug effects, genetics)
- Epidermal Growth Factor
(antagonists & inhibitors, genetics)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Glycogen Synthase Kinase 3
(antagonists & inhibitors, genetics)
- Glycogen Synthase Kinase 3 beta
- Humans
- Lignans
(administration & dosage)
- Mechanistic Target of Rapamycin Complex 1
- Mechanistic Target of Rapamycin Complex 2
- Mice
- Multiprotein Complexes
(antagonists & inhibitors)
- Phosphorylation
- Proto-Oncogene Proteins c-akt
(antagonists & inhibitors, genetics)
- Signal Transduction
(drug effects)
- TOR Serine-Threonine Kinases
(antagonists & inhibitors, genetics)
|